Literature DB >> 8722556

In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates.

M G Cormican, R N Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8722556     DOI: 10.1093/jac/37.4.847

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Trovafloxacin.

Authors:  M Haria; H M Lamb
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

2.  Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections.

Authors:  H P Endtz; J W Mouton; J G den Hollander; N van den Braak; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  In vitro extracellular and intracellular activity of two newer and two earlier fluoroquinolones against Listeria monocytogenes.

Authors:  B Facinelli; G Magi; M Prenna; S Ripa; P E Varaldo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

4.  Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.

Authors:  S H Zinner; D Gilbert; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Clinical evaluation of the tolerability and efficacy of trovafloxacin compared with sparfloxacin in the treatment of lower respiratory tract infections.

Authors:  J C Shobha; T R Kumar; N Deivanayagam; R B Singh; P Waghray; P A Babu; J Bhaduri; C C Sekhar
Journal:  Clin Drug Investig       Date:  2000       Impact factor: 2.859

Review 6.  Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.

Authors:  J C Pechère; T D Gootz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.